Dr Kiruba Nagaratnam is a stroke physician and geriatrician. He is the clinical lead for stroke medicine at the Royal Berkshire NHS Foundation Trust and clinical director for the Buckinghamshire, Oxfordshire and Berkshire Integrated Stroke Delivery Network. He is passionate about incorporating advancing technology into the care of stroke survivors. He has been instrumental in adopting artificial intelligence and digital technology in the acute stroke pathway in the Thames Valley region. The AF Champions programme he jointly led with the primary care physicians in West Berkshire and Oxford Academic Health Science Network has improved the detection and management of atrial fibrillation in the region. He is also involved in a research projects incorporating immersive virtual reality and artificial intelligence in stroke rehabilitation

Dr. Daria Namestnikova is Assistant Professor in the Department of Neurology, Neurosurgery and Medical Genetics of Pirogov Russian National Research Medical University and Senior Researcher in Federal Center of Brain Research and Neurotechnologies. Daria Namestnikova (1989 -) grew up in Moscow, Russia, where in 2012 graduated from Lomonosov Moscow State University and received Doctor of Medicine degree. In 2014 she finished her Neurology Residency and in 2018 PhD program at Pirogov Russian National Research Medical University. Her research interests include experimental neurology and neuroscience, stroke modeling, cell therapy and regenerative medicine, neurological disease in pregnancy and puerperium.

I am a Clinical Research Fellow in the Stroke Research Group of the University of Cambridge (UK). Previously, I completed my medical degree and my neurology training at the University of Florence (Italy). Then, I spent two years in the Stroke Centre of Lausanne University Hospital (Switzerland) working as a cerebrovascular fellow. Recently, I have completed a PhD in Clinical Neurosciences with a research project focused on the neuroimaging selection of acute ischemic stroke patients for late endovascular treatment. Cerebrovascular diseases are my main clinical and research field of interest. My research projects within the Stroke Research Group include lacunar strokes, brain imaging and genetics of small vessel disease. More recently, I became interested in studying the relationship between stroke and Covid-19, and I published a meta-analysis on this topic (doi: 10.1177/1747493020972922.)

Dr. Michelle Nelson is a Scientist in the Lunenfeld-Tanenbaum Research Institute at Sinai Health System and an Assistant Professor in the Institute of Health Policy, Management and Evaluation at the University of Toronto. Michelle leads international research teams focused on rehabilitation and community reintegration for people with complex care needs and is particularly interested in the role and contributions of volunteers and the third sector in integrated care. In 2020, Dr. Nelson was appointed the inaugural Chief Knowledge Officer for March of Dimes Canada (MODC) a national service organization that provides programs for people living with stroke. Having leadership roles in both research and practice environments creates opportunities for practice informed research, and leverages these insights to advance the design and implementation of evidence informed community based services. Dr. Nelson is also the Vice President (Stroke Support Organizations) for the World Stroke Organization.